Bioresonance therapy in the treatment of optic nerve atrophy in patients resistant to transcutaneous electrical stimulation
AUTHORS : Borisov1 T.V. | Egorov1,2 V.V. | Smolyakova1,2 G.P. | Guohua1 T.I.
RELEVANT UNIVERSITIES : 1Khabarovsk branch of FGAU “MNTK” Eye Microsurgery “them. acad. S.N.
Fedorov “Ministry of Health of the Russian Federation, 2KGBOU DPO “Institute for Advanced Studies of
Healthcare Professionals” of the Ministry of Health of the Khabarovsk Territory, Khabarovsk, Russia
YEAR : 2017
Optic nerve atrophy (ADN) is a severe polyetiological disease that occupies a leading place in the structure of eye disability [9]. At the same time, in the structure
of the causes of eye disability, ADH has more than doubled over the past two decades [7, 10]. Currently, guided by the experimentally established fact about the
reversibility of morphofunctional changes in the optic nerve (optic nerve) during its
atrophy, there has been an increased interest in physiotherapeutic treatment in
order to improve and stabilize visual functions [4, 6, 9].
